Helix Acquisition Corp. (HLXA) Prices $100M IPO

IPO
ipo
tough week

The IPO Market is Showing Signs of Further Indigestion

Oct 19, 2020 INTEL by Matt Cianci
Edoc Acquisition Corp. (ADOC), re-filed its S-1 this morning to re-up the value of its (already overfunded) trust. The move is the latest in the recent trend of SPACs overfunding their trust rather than expanding warrant coverage. In the case of ADOC, they are adding to their already overfunded trust, moving from $10.10 per unit
Read More

South Mountain Merger Corporation (SMMC) to Combine with Billtrust in $1.3Bn Deal

Fintech firm Billtrust announced this morning it has entered into a definitive business combination agreement with South Mountain Merger Corporation (NASDAQ: SMMC) that would give it an enterprise value of $1.293 billion. Lawrenceville, New Jersey-based Billtrust provides accounts receivable (AR) and accounts payable (AP) software with order-to-cash credit solutions to improve cashflow and eliminate paper
Read More
Legacy-onyx

Matt’s Top 3 SPAC Targets – Consumer in Europe

SPACInsider contributor Matt Cianci this week compiled his three favorite potential SPAC targets in the European consumer sector. We look at why they are compelling and why each could be a fit for a blank-check merger.  AUTO1 Group As we discussed in a previous Top 3, the “digitization of everything” trend is only going to
Read More
IPO-Pricing
IPO
paya-logo
forum - tattooed chef

Forum Merger II Shareholders Approve Tattooed Chef Combination

Forum Merger II Corporation (NASDAQ:FMCI) shareholders have approved the business combination with Ittella International at a special meeting this morning, per this afternoon’s press release. The newly created company, which is to be name the Tattooed Chef, will begin trading tomorrow, October 16, 2020, on Nasdaq under the ticker symbols “TTCF” and “TTCFW”, representing the common stock and warrants, respectively. ...READ MORE

LUMINAR
id-gemini-rgb2

FS Development Corp. (FSDC) to Combine with Gemini Therapeutics

Biotech firm Gemini Therapeutics announced this morning that it has entered into a definitive merger agreement with FS Development Corp. (NASDAQ:FSDC) that would give it a pro forma valuation of $265.6 million. Gemini is a clinical stage precision medicine company developing treatments for age-related macular degeneration (AMD) by developing drugging strategies that are matched to
Read More
ipo
motion-logo